July 18 (Reuters) -
* TSO3 Inc says has initiated studies in france in support of obtaining prion inactivation claims for that market
* TSO3 Inc says series of initiatives in support of a planned european launch of co's sterizone vp4 sterilizer this year Source text for Eikon: ID:nPn6CTHfCa Further company coverage: TOS.TO
(Bengaluru Newsroom +1-646-223-8780)